Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
Georgetown University Hospital
328
mi
from 43215
Washington,
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
Georgetown University Hospital
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
University of Miami Hospital
993
mi
from 43215
Miami, FL
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
University of Miami Hospital
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
Tampa General Hospital
831
mi
from 43215
Tampa, FL
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
Tampa General Hospital
831
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Floriday
971
mi
from 43215
Weston, FL
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Floriday
971
mi
from 43215
Weston, FL
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
432
mi
from 43215
Atlanta, GA
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
Piedmont Atlanta Hospital
432
mi
from 43215
Atlanta, GA
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
Piedmont Atlanta Hospital
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
University of Minnesota Medical Center - Twin Cities Campus
624
mi
from 43215
Minneapolis, MN
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Medical Center - Twin Cities Campus
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
Rutgers University Hospital
467
mi
from 43215
Newark, NJ
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
Rutgers University Hospital
467
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
138
mi
from 43215
Cleveland, OH
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
138
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
Drexel University College of Medicine
416
mi
from 43215
Philadelphia, PA
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
Drexel University College of Medicine
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
Methodist Dallas Medical Center - The Liver Institute
912
mi
from 43215
Dallas, TX
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
Methodist Dallas Medical Center - The Liver Institute
912
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
2005
mi
from 43215
Seattle, WA
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated:  12/31/1969
New York Univ. Medical Center
477
mi
from 43215
New York, NY
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Status: Enrolling
Updated: 12/31/1969
New York Univ. Medical Center
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital Cancer Center
643
mi
from 43215
Boston, MA
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital Cancer Center
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas
Status: Enrolling
Updated:  12/31/1969
Kansas City Veterans Affairs Medical Center
618
mi
from 43215
Kansas City, MO
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas
Status: Enrolling
Updated: 12/31/1969
Kansas City Veterans Affairs Medical Center
618
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University Hospital
416
mi
from 43215
Philadelphia, PA
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University Hospital
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas
Status: Enrolling
Updated:  12/31/1969
Fox Chase Cancer Center
420
mi
from 43215
Philadelphia, PA
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas
Status: Enrolling
Updated: 12/31/1969
Fox Chase Cancer Center
420
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Cancer Institute (UPCI)
166
mi
from 43215
Pittsburgh, PA
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Cancer Institute (UPCI)
166
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas
Status: Enrolling
Updated:  12/31/1969
Univ of Puerto Rico
1802
mi
from 43215
San Juan,
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas
Status: Enrolling
Updated: 12/31/1969
Univ of Puerto Rico
1802
mi
from 43215
San Juan,
Click here to add this to my saved trials
IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis
IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis
Status: Enrolling
Updated:  12/31/1969
Children's Medical Center of Dallas
911
mi
from 43215
Dallas, TX
IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis
IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis
Status: Enrolling
Updated: 12/31/1969
Children's Medical Center of Dallas
911
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Olive View - UCLA Medical Center
1975
mi
from 43215
Sylmar, CA
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Olive View - UCLA Medical Center
1975
mi
from 43215
Sylmar, CA
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
University of Maryland Medical Center
343
mi
from 43215
Baltimore, MD
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
University of Maryland Medical Center
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System
165
mi
from 43215
Detroit, MI
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System
165
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Wayne State University - Sinai Grace Hospital
163
mi
from 43215
Detroit, MI
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Wayne State University - Sinai Grace Hospital
163
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Hackensack University Medical Center
476
mi
from 43215
Hackensack, NJ
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Hackensack University Medical Center
476
mi
from 43215
Hackensack, NJ
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Cohen's Children's Medical Center of NY
494
mi
from 43215
New Hyde Park, NY
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Cohen's Children's Medical Center of NY
494
mi
from 43215
New Hyde Park, NY
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Long Island Jewish Medical Center
494
mi
from 43215
New Hyde Park, NY
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Long Island Jewish Medical Center
494
mi
from 43215
New Hyde Park, NY
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Staten Island University Hospital North
473
mi
from 43215
Staten Island, NY
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Staten Island University Hospital North
473
mi
from 43215
Staten Island, NY
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Stony Brook University
549
mi
from 43215
Stony Brook, NY
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Stony Brook University
549
mi
from 43215
Stony Brook, NY
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
University of Florida - Jacksonville
668
mi
from 43215
Jacksonville, FL
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
University of Florida - Jacksonville
668
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
South Shore Hospital
646
mi
from 43215
South Weymouth, MA
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
South Shore Hospital
646
mi
from 43215
South Weymouth, MA
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Hennepin County Medical Center
623
mi
from 43215
Minneapolis, MN
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Hennepin County Medical Center
623
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Kings County Hospital
481
mi
from 43215
Brooklyn, NY
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Kings County Hospital
481
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
McAllen Primary Care
1291
mi
from 43215
McAllen, TX
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
McAllen Primary Care
1291
mi
from 43215
McAllen, TX
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
University Hospital of Brooklyn
480
mi
from 43215
Brooklyn, NY
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
University Hospital of Brooklyn
480
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Kern Medical Center
1977
mi
from 43215
Bakersfield, CA
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Kern Medical Center
1977
mi
from 43215
Bakersfield, CA
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
UC Davis
2042
mi
from 43215
Sacramento, CA
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
UC Davis
2042
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
991
mi
from 43215
Houston, TX
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
North Shore University Hospital
493
mi
from 43215
Manhasset, NY
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
North Shore University Hospital
493
mi
from 43215
Manhasset, NY
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
UPMC Mercy
163
mi
from 43215
Pittsburgh, PA
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
UPMC Mercy
163
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
CityDoc Urgent Care
909
mi
from 43215
Dallas, TX
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
CityDoc Urgent Care
909
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated:  12/31/1969
Washington University in St. Louis
398
mi
from 43215
Saint Louis, MO
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Status: Enrolling
Updated: 12/31/1969
Washington University in St. Louis
398
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials